Short Interest in Apollomics, Inc. (NASDAQ:APLMW) Drops By 61.9%

Apollomics, Inc. (NASDAQ:APLMW) was the recipient of a large decline in short interest in the month of January. As of January 31st, there was short interest totalling 7,200 shares, a decline of 61.9% from the January 15th total of 18,900 shares. Based on an average daily trading volume, of 86,900 shares, the days-to-cover ratio is presently 0.1 days.

Apollomics Trading Up 9.1 %

APLMW stock opened at $0.01 on Friday. Apollomics has a 12-month low of $0.01 and a 12-month high of $0.04. The business’s fifty day moving average price is $0.01 and its 200 day moving average price is $0.01.

About Apollomics

Apollomics, Inc, a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.